journal article·2026-01

Spectroscopic and computational evaluation of 4-chlorochalcone as a promising therapeutic candidate against cervical cancer

R. Sangeetha, R. Senthil Kumar, Nachammai Kathiresan, T. Rajesh Kumar, Pandi Sangavi, Langeswaran Kulanthaivel

Applied Physics A· Volume 132· Issue 1
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nonlinear Optical Materials Research · Cancer Research and Treatment · Synthesis and biological activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (28)

Show source-provided references
1. GLOBOCAN 2020: New global cancer data. Available online: https://www.uicc.org/news/globocan-2020-new-global-cancer-data (accessed on 25 May 2021)
2. P. Bober, M. Alexovič, Z. Tomková, R. Kilík, J. Sabo, RHOA and mDia1 promotes apoptosis of breast cancer cells via a high dose of doxorubicin treatment. Open Life Sci. 14, 619–627 (2019)10.1515/biol-2019-0070 ↗
3. A.M. Almeida, J.A. Queiroz, F. Sousa, A. Sousa, Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discov. Today 24, 2044–2057 (2019)10.1016/j.drudis.2019.07.011 ↗
4. A. Pal, R. Kundu, Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy. Front. Microbiol. 10, 3116 (2019)10.3389/fmicb.2019.03116 ↗
5. E.S. Prigge, M. von KnebelDoeberitz, M. Reuschenbach, Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations. Mutat. Res. Rev. Mutat. Res. 772, 51–66 (2017)10.1016/j.mrrev.2016.06.005 ↗
6. M.N. Cordeiro, R.D.C.P.D. Lima, F. Paolini, A.R.S. Melo, A.P.F. Campos, A. Venuti, A.C. De Freitas, Current research into novel therapeutic vaccines against cervical cancer. Expert Rev. Anticancer Ther. 18, 365–376 (2018)10.1080/14737140.2018.1445527 ↗
7. F. Barra, D. Lorusso, U. Leone Roberti Maggiore, A. Ditto, G. Bogani, F. Raspagliesi, S. Ferrero, Investigational drugs for the treatment of cervical cancer. Expert Opin. Investig. Drugs 26, 389–402 (2017)10.1080/13543784.2017.1302427 ↗
8. D. Gomes, S. Silvestre, A.P. Duarte, A. Venuti, C.P. Soares, L. Passarinha, Â. Sousa, In silico approaches: a way to unveil novel therapeutic drugs for cervical cancer management. Pharmaceuticals 14(8), 741 (2021). https://doi.org/10.3390/ph1408074110.3390/ph14080741 ↗
9. M.A. Islam, M.S. Hossain, S. Hasnat et al., In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy. Sci. Rep. 14, 17182 (2024). https://doi.org/10.1038/s41598-024-65112-210.1038/s41598-024-65112-2 ↗
10. Bz. Ren, M. Ablise, Xc. Yang et al., Synthesis and biological evaluation of α-methyl chalcone for anti-cervical cancer activity. Med. Chem. Res. 26, 1871–1883 (2017). https://doi.org/10.1007/s00044-017-1891-010.1007/s00044-017-1891-0 ↗
11. K. Langeswaran, S. Algarni, M. Muthuramamoorthy, P. Saravanan, R. Premkumar, R. Sangeetha, 4-fluorochalcone as a novel therapeutic agent for cervical cancer: an in depth spectroscopic and computational study. J. Mol. Struct. 1326, 141130 (2025)10.1016/j.molstruc.2024.141130 ↗
12. R. Anitha, R. Sangeetha, E.A.J.Y. Prabha, J. Sangavi, K. Langeswaran, Synthesis, crystallization, XRD, Hirshfeld surface, vibrational spectra, and quantum chemical studies and computational investigation of Caffeinium bisulfate: a new noncentrosymmetric form. J. Biomol. Struct. Dyn. 41(3), 982–999 (2023)10.1080/07391102.2021.2015445 ↗
13. J.O. Anhaia-Machado, A.C.G. Soares, C.A.S. de Oliveira Pinto, A.I.Á. Barrera, A.R. Baby, G.H.G. Trossini, Molecular modeling based on time-dependent density functional theory (TD-DFT) applied to the UV-Vis spectra of natural compounds. Chemistry 5(1), 41–53 (2022)10.3390/chemistry5010004 ↗
14. N. Kanagathara, R. Usha, V. Natarajan, M.K. Marchewka, Molecular geometry, vibrational, NBO, HOMO–LUMO, first order hyperpolarizability and electrostatic potential studies on anilinium hydrogen oxalate hemihydrate–an organic crystalline salt. Inorg. Nano-Met. Chem. 52(2), 226–233 (2022)10.1080/24701556.2021.1891103 ↗
15. R. Sangeetha, E.A.J.Y. Prabha, A. Lakshmi, P. Sangavi, K. Langeswaran, Molecular docking and dynamic simulations of Ocimum basilicum compounds against HCC and structural, vibrational, quantum, and chemical investigation of campesterol. J. Biomol. Struct. Dyn. 40(24), 13997–14012 (2022)10.1080/07391102.2021.1997816 ↗
16. D. Ghosh, J. Griswold, M. Erman, W. Pangborn, Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 457(7226), 219–223 (2009)10.1038/nature07614 ↗
17. P. Sangavi, G.R. Shri, S.K. Singh, K. Langeswaran, A computational perception of BBOX1-IP3R3 interaction uncovers inhibitors for dysregulated calcium signalling in triple negative breast cancer. SAR QSAR Environ. Res. 36(4), 305–332 (2025)10.1080/1062936X.2025.2497380 ↗
18. N. Kathiresan, S. Pandi, T.P. Sahul, G.K. Subbaraj, P. Ganapathy, K. Chandrashekar, L. Kulanthaivel, Exploration and validation of lead molecules against yellow fever through high throughput virtual screening and molecular dynamics simulation. Lett. Drug Des. Discov. 21(8), 1417–1428 (2024)10.2174/1570180820666230223113742 ↗
19. A. Parihar, Z.F. Sonia, F. Akter, M.A. Ali, F.T. Hakim, M.S. Hossain, Phytochemicals based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: a promising therapeutic approach for tackling COVID 19. Comput. Biol. Med. 145, 105468 (2022)10.1016/j.compbiomed.2022.105468 ↗
20. S. Infant Deepthi, P. Sangavi, G. Priyanka, C. Kirubhanand, K.T. Nachammai, Discovery of potential inhibitors for SFRP3: ligand-based 3D pharmacophore, virtual screening, molecular docking, and dynamics studies. Polycycl. Aromat. Compd. (2024)
21. E. Broni, A. Striegel, C. Ashley, P.O. Sakyi, S. Peracha, M. Velazquez, K. Bebla, M. Sodhi, S.K. Kwofie, A. Ademokunwa, S. Khan, Molecular docking and dynamics simulation studies predict potential anti-ADAR2 inhibitors: implications for the treatment of cancer, neurological, immunological and infectious diseases. Int. J. Mol. Sci. 24(7), 6795 (2023)10.3390/ijms24076795 ↗
22. R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, T.A. Halgren, P.C. Sanschagrin, D.T. Mainz, Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes. J. Med. Chem. 49(21), 6177–6196 (2006)10.1021/jm051256o ↗
23. Y.J.N. Chen, R.C. Shi, Y.C. Xiang, L. Fan, H. Tang, G. He, M. Zhou, X.Z. Feng, J.D. Tan, P. Huang, X. Ye, Malate initiates a proton-sensing pathway essential for pH regulation of inflammation. Signal Transduct. Target. Ther. 9(1), 367 (2024)10.1038/s41392-024-02076-9 ↗
24. M. Allegra, M. Tutone, L. Tesoriere, A. Attanzio, G. Culletta, A.M. Almerico, Evaluation of the IKKβ binding of indicaxanthin by induced-fit docking, binding pose metadynamics, and molecular dynamics. Front. Pharmacol. 12, 701568 (2021)10.3389/fphar.2021.701568 ↗
25. P. Sangavi, K.T. Nachammai, K. Langeswaran, Explication of pharmacological proficiency of phytoconstituents from Adansonia digitata Bark: An in vitro and in silico approaches. Scientifica 6645824 (2024)10.1155/2024/6645824 ↗
26. M. Hawash, N. Jaradat, R. Sabobeh, M. Abualhasan, M.T. Qaoud, New thiazole carboxamide derivatives as COX inhibitors: design, synthesis, anticancer screening, in silico molecular docking, and ADME profile studies. ACS Omega 8(32), 29512–29526 (2023)10.1021/acsomega.3c03256 ↗
27. M. Sureshan, D. Prabhu, K. Saraboji, Structure-based designing of anti-filarial molecules targeting the key antioxidant enzyme glutathione peroxidase (GPx) of Wuchereria bancrofti: an integrated in silico and in vitro approach. Comput. Biol. Med. 195, 110669 (2025)10.1016/j.compbiomed.2025.110669 ↗
28. C. Nayak, S.K. Singh, In silico identification of natural product inhibitors against Octamer-binding transcription factor 4 (Oct4) to impede the mechanism of glioma stem cells. PLoS ONE 16(10), e0255803 (2021)10.1371/journal.pone.0255803 ↗